610 Non-invasive predictive factors of complete cytoreduction at interval debulking surgery in advanced epithelial ovarian cancer
G Candotti, G Pavone, L Bocciolone, F Vasta, F Galli… - 2024 - ijgc.bmj.com
Introduction/Background Complete cytoreduction (macroscopic Residual Tumor, RT= 0) is
an independent prognostic factor in advanced epithelial ovarian cancer (AEOC). There are …
an independent prognostic factor in advanced epithelial ovarian cancer (AEOC). There are …
672 Tubal histopathological abnormalities after risk-reducing salpingo-oophorectomy: does BRCA mutation type influence the age of onset?
E Rabaiotti, FM Vasta, R Cioffi, M Di Filippo, C Sabini… - 2024 - ijgc.bmj.com
Introduction/Background Risk Reducing Salpingo-Oophorectomy (RSSO) is the main
prophylactic option in BRCA-mutated patients. Current evidence indicates that the first step …
prophylactic option in BRCA-mutated patients. Current evidence indicates that the first step …
2022-RA-1072-ESGO Optimal cytoreduction for advanced epithelial ovarian cancer: non invasive predictive factors
G Candotti, A Bergamini, R Cioffi, P de Marzi… - 2022 - ijgc.bmj.com
Introduction/Background Standard treatment for advanced ovarian cancer patients should
be primary cytoreduction followed by platinum-based chemotherapy. The aim of surgical …
be primary cytoreduction followed by platinum-based chemotherapy. The aim of surgical …
2022-RA-1433-ESGO Reproductive outcomes after conservative treatment in malignant ovarian germ cell tumors (MOGCTs) patients: a MITO-9 study
A Bergamini, F Vasta, L Bocciolone… - International …, 2022 - search.proquest.com
Results 164 patients were sent the questionnaire, that was completed by 114 patients
(69.5%). Among all patients, 38 (33.3%) expressed a desire for pregnancy, 29 (76.3%) of …
(69.5%). Among all patients, 38 (33.3%) expressed a desire for pregnancy, 29 (76.3%) of …